Colorectal, Cancer Clinical Trials in Harbin, Heilongjiang
6 recruitingHarbin, Heilongjiang, China
Showing 1–6 of 6 trials
Recruiting
Phase 1
First in Human Study of SIM0610 in Solid Tumors
Colorectal, CancerHepatocellular CarcinomaNon-small Cell Lung Cancer+2 more
Jiangsu Simcere Pharmaceutical Co., Ltd.260 enrolled7 locationsNCT07348211
Recruiting
Phase 1Phase 2
Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal Cancer
Colorectal, Cancer
AbbVie30 enrolled8 locationsNCT06464692
Recruiting
Phase 4
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
Colorectal, Cancer
Fudan University756 enrolled9 locationsNCT06090994
Recruiting
Phase 1Phase 2
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
Colorectal, CancerNon-small Cell Lung CancerKRAS P.G12C+1 more
Allist Pharmaceuticals, Inc.240 enrolled27 locationsNCT05288205
Recruiting
Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
Colorectal, Cancer
Xi Shan Wang3,060 enrolled22 locationsNCT03349762
Recruiting
Phase 1
A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
Colorectal, CancerPancreatic CancerNon-small Cell Lung Cancer+1 more
Qilu Pharmaceutical Co., Ltd.250 enrolled5 locationsNCT06403735